KRAS and pancreatic ductal adenocarcinoma: Since KRAS harbors the oncogenic mutation G12V in approximately 30% of pancreatic ductal adeno carcinoma and 20% of the colon and non-small cell lung cancers, we used the algorithm ProtAG for theoretical prediction of spliced peptides delineated from the KRASG12V2-35 protein sequence.